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Abstract 
Background: Cardiac myxoma is a benign tumor that carries the risk of 
embolization and obstruction of the blood flow. The ideal surgical approach is still 
debatable. We present our experience in the surgical treatment of cardiac 
myxomas and its ideal surgical approach.  
Methods: We retrospectively analyzed the data for all patients who underwent 
surgical excision of cardiac myxoma at our institution over 11 years starting from 
January 2006 to December 2016. Descriptive statistics were used to present 
preoperative, operative and postoperative data and Kaplan Meier curve to plot 
long-term survival.  
Results: Twenty-one patients had surgical excision of a primary, single and 
sporadic cardiac myxoma. Thirteen patients (62 %) were females, and the mean 
age at operation was 55.2 years (range: 28 – 71 years). The location of myxomas 
was in the left atrium in 17 patients (81%) and right atrium in 4 patients (19 %). 
Dyspnea was the main presenting symptom (71.4%) followed by constitutional 
symptoms (28%), palpitations (23.8%), syncope (14.2%) and stroke (14.2%). A 
right atrial trans-septal incision was used in 76.5% of left atrial myxoma cases. 
Five patients had concomitant operative procedures (coronary artery bypass 
grafting (n=2), tricuspid valve repair (n=1), mitral valve replacement (n=1) and 
bullectomy (n=1)). Postoperative complications were reported in six patients 
(28.6%) (supraventricular arrhythmia (n=2), temporary conduction deficit (n=2), 
pulmonary atelectasis (n=1), and postoperative bleeding (n=1)). Early 
postoperative mortality occurred in one patient (4.76 %), and there were no late 
deaths related to myxoma. 
Conclusion: Surgical treatment of cardiac myxoma is safe with low morbidity and 
mortality. The right atrial trans-septal incision is the recommended surgical 
approach. 
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Introduction 
Cardiac myxoma is the most common benign 
cardiac tumor [1].  Approximately 75% to 80% of 
myxomas are located in the left atrium (LA), 10% 
to 20% are in the right atrium (RA), and from 2% 
to 4% in the ventricles [2]. Multicentric myxoma 
was reported more commonly in familial variety 
with autosomal dominant inheritance [1]. 
Myxomas occur more frequently in females, and 
all age groups are affected; however, they present 
more likely between the third and sixth decades 
of life [3]. Although myxomas are benign, they 
carry the risk of systemic embolization with 
subsequent cerebral or peripheral infarctions, 
intra-cardiac obstructions, syncope, and sudden 
death; therefore, once the diagnosis is 
established, immediate surgical resection is 
recommended [4]. There is a debate about the 
best surgical approach to intra-cardiac myxoma 
[5]. In this study, we present our clinical 
experience in the diagnosis and surgical 
treatment of cardiac myxomas over 10 years. 
Different surgical approaches were discussed to 
elucidate their impact on surgical outcomes.  
Patients and Methods: 
Study design and population: 
This retrospective cohort study was conducted 
at our tertiary referral university hospital. All 
cardiac myxoma patients who underwent an 
operation at our Cardiothoracic Surgery 
Department in the period from January 2006 to 
December 2016 were enrolled in the study. 
Complete data of those patients were extracted 
from the department database after approval of 
the Ethical Committee of the University, and 
patients’ consent was waived due to the 
retrospective nature of the study. The 
preoperative, operative and postoperative details 
were collected and analyzed.  
Preoperative data: 
Preoperative data included age, sex, main 
complaint, other symptoms, the time interval 
from the onset of symptoms to diagnosis and 
family history of cardiac tumors. Preoperative 
diagnosis was established in all patients by 
echocardiography (Figure 1). Preoperative 
coronary angiography was performed in patients 
older than 40 years and younger patients when 
suspecting coronary artery disease. Once the 
diagnosis of cardiac myxoma was confirmed, the 
patients were referred for urgent surgery. 
Figure 1: Trans-thoracic echocardiography of left atrial 
myxoma. AO: Aorta, LA: left atrium, LV: left ventricle, 
RVOT: Right ventricular outflow tract. 
Operative data: 
The tumor site, size, gross picture, attachment 
details, defects created, and its repair, operative 
events, and concomitant operative procedures 
were reported. All patients were operated upon 
through median sternotomy. Cardiopulmonary 
bypass was initiated using aortic and bi-caval 
cannulation, and moderate hypothermia was used 
in all patients. After aortic cross-clamp, antegrade 
cold blood cardioplegia was infused. Intra-
operative trans-esophageal echocardiography 
was done routinely in all cases by 
anesthesiologists to evaluate the valve function 
after resection of the tumor and to exclude any 
residual lesion. The heart was not manipulated 
until the aorta had been cross-clamped to avoid 
tumor fragmentation and systemic embolization.  
In case of right atrial myxoma and left atrial 
myxoma with a shunt, pulmonary artery was 
included in the aortic cross-clamp to avoid 
pulmonary embolization. The surgical approach 
for left atrial myxoma was either through left 
atriotomy or bi-atriotomy (LA+RA) or right atrial 
trans-septal approach (RA+TS) (Figure 2), right 
atriotomy was used for right atrial myxoma 
(Figure 3). To avoid the recurrence of the tumor, 
the resection was complete with full thickness 
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Figure 2: (A, B, C) Illustration of the excision of left atrial myxoma through a right atrial trans-septal approach
removal of the attachment of the base even if it is 
attached to the valve leaflets. The surgically 
created defect was sutured directly or repaired 
with an autologous pericardial patch. After 
excision of the tumor, the related heart chambers 
were irrigated by copious cold saline and 
suctioned by using high-speed wall suction to 
eliminate any loose tumor fragments that might 
have been dislodged during manipulation and 
removal of the tumor. All the removed myxomas 
were subjected to histopathological examination 
(Figure 4).  
Figure 3: Excision of right atrial myxoma through right 
atriotomy incision. IVC: Inferior vena cave, SVC: 
Superior vena cava 
Postoperative care: 
Early postoperative all-cause morbidities and 
mortalities were reported. The follow-up time 
ranged from 5 to 120 months, and it was complete 
for 75% of cases at five years and 70% at ten years. 
Complete follow up was available for 14 patients 
of the operative survivors, while six patients were 
lost to follow up.  
Statistical analysis: 
Statistical analyses were conducted using the 
SPSS (Version 20) statistical software for Windows 
(IBM Corporation, Chicago, IL, USA). The data were 
presented as mean ± standard deviation or range 
for continuous variables and as numbers with 
percentages for categorical variables. The long-
term cumulative survival analysis was plotted 
using the Kaplan-Meier curve. 
Results 
Twenty-one patients with primary cardiac 
myxomas were operated upon at our department 
during the period from January 2006 to December 
2016. Thirteen patients (62%) were females, and 
eight patients (38%) were males. The mean age 
was 55.2 years (age ranged between 28 and 71 
years). Ten patients (48%) were in the age group 
51-60 years, and four patients (19 %) were in the 
age group 61-70 years. Seventeen (81%) myxomas 
were in the left atrium and four (19 %) located in 
the right atrium. The duration elapsed from the 
onset of symptoms to the diagnosis ranged from 1 
to 8 months. 
 Dyspnea was the main presenting symptom 
(71.4%) followed by constitutional symptoms 
(generalized fatigue, fever, and weight loss) (28%), 
palpitations (23.8%), syncope (14.2%) and stroke 
(14.2%). Peripheral embolism, chest pain, and 
lower limb edema were presented equally
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Figure 4: Gross (A, B) and microscopic picture (C) of excised left atrial myxoma
 (4.76%). One patient presented by 
cardiogenic shock (4.76%) (Table 1). 
None of the patients had a family history of 
myxoma. Eighteen patients (85.7%) had 
preoperative coronary angiography; two of them 
had a significant coronary artery disease and had 
coronary artery bypass grafting (CABG) as a 
concomitant procedure to myxoma resection. 
Sixteen out of the seventeen left atrial myxoma 
(94%) originated from the inter-atrial septum and 
one (6%) from the posterior leaflet of mitral valve. 
Table 1: Demographic data and symptoms of myxoma 
patients. (n is the number of cases) 
Total number (n= 21) 
Sex Females n= 13 61.90% 
Males n= 8  38.10% 
Age Range (Years) 28.71 
Mean age (Years) 55.2 
20 – 30 n= 1 4.76% 
31 – 40 n= 2 9.52% 
41 – 50 n= 3 14.20% 
51 – 60 n= 10 48.0% 
61 – 70 n= 4 19.0% 
71 – 80 n= 1 4.76% 
Symptoms Dysnea n= 15 71.40% 
Syncope n= 3 14.20% 
Palpitation n= 5 23.80% 
Lower limb 
edema 
n= 1 4.76% 
Chest pain n= 1 4.76% 
Stroke n= 3 14.20% 
Peripheral 
embolism 
n= 1 4.76% 
Constitutional 
symptoms 
n= 6 28.0% 
Cardiogenic shock n= 1 4.76% 
All right atrial myxomas (100%) originated from 
the inter-atrial septum. After complete excision of 
myxomas; a pericardial patch was used to close 
the resulting septal defect.  
Four patients with left atrial myxoma resection 
had concomitant procedures, 2 had CABG, one 
had mitral valve replacement (MVR), and one had 
stapler resection of emphysematous bulla of the 
right upper lung lobe. One case of right atrial 
myxoma resection had concomitant tricuspid 
valve repair using De-Vega annuloplasty.  
The size of the excised tumors ranged from 1.5 
× 2.5 cm to 5 × 7 cm. The gross appearance of the 
tumor was a soft, gelatinous, sessile or 
pedunculated mass with either a villous or smooth 
surface. Histopathological examination confirmed 
the diagnosis of myxoma in all patients.  
Six patients (28.6%) had postoperative 
complications; supraventricular arrhythmia in 2 
patients who were controlled medically, 
temporary conduction deficit which was managed 
by temporary pacing in 2 patients, pulmonary 
atelectasis in one patient who was managed by 
bronchoscopy, and postoperative bleeding in one 
patient who needed re-exploration. 
 Fourteen patients were in NYHA class I (66.7%) 
postoperatively compared to ten patients (47.6%) 
in NYHA class III preoperatively. Early 
postoperative mortality (defined as death 
occurring within 30 days of operation) was 
reported in one patient (4.76%). There was no 
myxoma related late deaths (defined as death 
occurring after 30 days of the operation) (Table 2 
and Figure 5).  
Discussion 
Cardiac myxomas usually affect adults 
between the third and sixth decades of life and 
have female gender predilection [6]. In our series, 
Figure 5: Kaplan-Meier cumulative survival curve for 
patients with cardiac myxoma who underwent 
surgical resection. 
61.9% of the patients were females, which is 
similar to other published series [1]. On the other 
hand, female gender predominance is less 
pronounced in familial cardiac myxomas [7]. 
None of the patients in our study expressed 
familial inheritance.  
Cardiac myxoma may arise from the  left 
atrium, right atrium, the atrioventricular valves, 
the ventricles, or may rarely originate from the 
ventricular free wall  or atrial appendages [4], All 
the published series in the literature showed that 
the left atrium is the most common site of 
myxoma, with the tumor base on the inter-atrial 
septum in 80% of the cases. [4, 8, 9]. In sporadic 
reported cases, the tumor was attached to the 
valve leaflets or in other locations in the left atrial 
or ventricular wall [10]. The attachment site in 
our cases was atrial septum except for one tumor 
which was attached to the posterior mitral valve 
leaflet. 
In our patients, the location of the myxoma 
was in the left atrium in 17 patients (81%) and 
right atrium in 4 patients (19%) with no reported 
ventricular or multicentric myxoma. In the 
literature, few cases of multicentric non-familial 
bi-atrial myxoma were reported [11-14]. 
Additionally, ventricular locations of the myxoma 
were reported rarely in other case series. Mishra 
and colleagues reported the occurrence of one 
right ventricular myxoma in a series of 50 cases 
over four years [15], and Stevens and associates 
reported a case of left ventricular myxoma in 
a series of 58 cases over 25 years in Canada [16].  
Microscopically, myxoma is generally a 
hypocellular lesion with the prominent myxoid 
stromal background. The neoplastic cells are 
frequently stellate, or spindle in shape and tend to 
arrange singly or less frequently in small cords or 
nests and intramural hemorrhage and 
calcification were occasionally present [4]. In our 
series, the histopathological diagnosis was 
confirmed in all patients. 
Clinical presentation of cardiac myxomas is 
characterized by a wide range of symptoms and 
signs, from being asymptomatic to the life-
threatening presentation. Dyspnea is the most 
common reported cardiac symptom; other cardiac 
symptoms like palpitation, syncope, congestive 
heart failure, and acute pulmonary edema were 
also reported [17]. Catastrophic presentation of 
acute cardiogenic shock and sudden death was 
reported which may be due to complete mitral 
valve obstruction, massive coronary embolization 
or massive pulmonary embolism [18]. One of our 
cases presented by cardiogenic shock and 
echocardiography revealed near-complete 
obstruction of the blood flow through the mitral 
valve by a large mobile mass. The patient was 
placed immediately in a steep Trendelenburg 
position to dislodge the tumor towards the atrial 
cavity and had an emergency operation. The most 
frequent symptom in our study was dyspnea 
(71.4%) followed by constitutional symptoms 
(28%) and palpitation (23.80%).  
Trans-thoracic echocardiography (TTE) is the 
main tool for diagnosis of intra-cardiac tumors. 
Echocardiographic detection of a pedunculated, 
smooth mobile mass sitting in the LA is almost 
pathognomonic of LA myxoma [19]. Trans-
esophageal echocardiography (TEE) can detect 
masses as small as 1-3 mm and provide more 
details about the exact location, dimensions, and 
appearance of the tumor, but it is not used 
routinely for diagnosis, it is reserved for cases of 
unsure diagnosis or intra-operative assessment 
[20]. In our series, the tumors were diagnosed in 
all cases by TTE. Intra-operatively, TEE was used in 
all cases as one of the standard intra-operative 
invasive monitoring tools; it evaluates the valve 
function post-tumor resection and excludes any 
missed tumors. Cardiac MRI and CT scanning
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Table 2: Operative and postoperative data of the patients who underwent surgical resection of cardiac myxoma 
Variables Number Percent 
 Myxoma Location Left atrium 17 81% 
Right atrium 4 19% 
Surgical Approach to RA myxoma Right atriotomy 4 100% 
Surgical Approach to LA myxoma  
Uni-atrial (left atriotomy) 1 5.90% 
Bi-atrial (LA incision +RA incision) 3 17.60% 
Right atrial trans-septal 13 76.50% 
Associated Procedures 5 23.80% 
CABG 2 
Tricuspid valve repair 1 
Mitral valve replacement 1 
Bullectomy 1 
Postoperative Complications 6 28.60% 
AF 2 
Atelectasis 1 
Temporary conduction defect 2 
Bleeding (revision) 1 
Peri-operative Mortality 1 4.76% 
ICU Stay (mean± SD) 2.1±0.6 days 
Hospital Stay (mean± SD) 8.4±1.6 days 
Cross-Clamp Time (Min) (mean± SD) 20-130 (35) 
CPB Time (Min) (mean± SD) 30- 170 (55 min) 
NYHA functional class (Preoperative) 
I 3 14.30% 
II 6 28.60% 
III 10 47.60% 
IV 2 9.50% 
NYHA functional class (Postoperative) 
I 14 66.70% 
II 5 23.80% 
III 1 4.76% 
IV 1 4.76% 
. RA: Right Atrium; LA: Left Atrium; CABG: Coronary Artery Bypass Grafting; AF: Atrial Fibrillation; 
CPB: Cardio-Pulmonary Bypass; NYHA: New York Heart Association. 
provide additional information regarding the 
extent of tumor within the heart or into adjacent 
structures. Contrast enhancement of these 
techniques can differentiate tumors from 
thrombi, and fat-suppression techniques define 
other benign tumors such as lipomas [21]. 
 When the diagnosis of atrial myxomas is 
established, surgical excision must be performed 
as soon as possible to eliminate the potential risk 
of sudden death from complete valvular 
obstruction or massive embolization [1, 4, 17]. The 
classic concept of emergency treatment of cardiac 
myxoma is rarely questioned; some authors 
suggest that the emergency operation should be in 
patients with acute symptoms such as heart failure 
and pulmonary edema, clapper-shaped tumor 
intermittently prolapsing into the mitral orifice or 
a large lobulated tumor with a high risk of 
embolism [22]. Bakery and colleagues suggest 
that, except for real emergencies, myxoma 
patients should comply with the usual 
recommendations and preparations like any 
cardiac surgery. The preoperative assessment 
should take 1 or 2 days, which does not constitute 
a high risk for stable patients but allows surgery to 
be performed under better conditions, 
particularly in elderly patients [7]. In our series, 
we operated upon the patients as soon as the 
diagnosis was established, either on the same day 
for unstable patients or next morning list for stable 
cases.  
The basic principles of surgical resection of 
cardiac myxomas include adequate resection of 
the tumor, avoiding intra-operative embolization 
by the limitation of cardiac manipulation before 
aortic cross-clamping, avoiding excessive tumor 
manipulations to prevent fragmentation and 
meticulous intra-cardiac examination and 
irrigation to avoid leaving residual tumor [23]. In 
cases where the tumor is located at the close 
vicinity of the conduction tissue, the tumor 
resection is inevitably confined to the sub-
endocardial level, rather than full thickness tissue 
removal. In these patients, close follow-up is 
necessary to rule out possible recurrence [24]. In 
our series; complete left atrial tumor resection 
with safety margins affected the integrity of the 
mitral valve in one case, where the tumor was 
located at the posterior mitral valve leaflet, so the 
procedure was accompanied by mitral valve 
replacement in this patient.  
The routine surgical access is through the 
classic midline sternotomy. Recently, some 
authors have been tried minimal access surgery 
for cardiac myxoma resection; however, it was 
associated with longer operative time than the 
traditional approach. The minimally invasive 
approach has the advantages of shorter ICU and 
hospital stay, less postoperative pain and better 
cosmetic results. Tarui and colleagues reported a 
successful totally endoscopic robotic resection of 
left atrial myxoma in a 68-year old man using the 
Da Vinci Surgical System [25]. Opponents to 
minimal access surgery for cardiac myxoma, claim 
that these techniques can increase tumor 
manipulation; thus, increasing the possibility of 
local tumor seeding and systemic embolization 
[1]. Minimal access surgery has not been tried in 
our series.  
The known routes for excision of the left atrial 
myxoma are either left atrial or bi-atrial incisions. 
The bi-atrial approaches included left and right 
atriotomy (LA + RA), a right atriotomy + trans-
septal incision (RA + TS) or a left atriotomy + right 
atriotomy + trans-septal incision (LA +RA +TS). 
Right atrial myxoma can be excised through a right 
atrial incision only (RA) or right atrial incision plus 
trans-septal (TS) incision (RA+TS) [16].  
In our series, we used the isolated left atrial 
approach in one case (5.8 %), in which the 
myxoma was located on the posterior mitral valve 
leaflet. Conversely, Jones and colleagues in their 
published series reported the use of left atrial 
approach in 34% of the cases [24]. Lee and 
colleagues advocated that a left atriotomy should 
be performed first, then the position and shape of 
the tumor is evaluated, and, if the tumor can be 
removed without manipulation, it is removed 
without an additional incision.  If the attachment 
site and the margins are not obvious and excessive 
manipulation is expected, an additional right 
atriotomy is performed [23]. 
The bi-atriotomy approach (LA incision + RA 
incision ± TS) to cardiac myxomas was 
popularized by Cooley in 1973 [26] its advantages 
are excellent exposure and localization of the 
resection margin by direct visualization of the 
tumor pedicle, minimal manipulation of the 
tumor and it allows examination of all cardiac 
chambers and easy repair the septal defect [23]. 
On the other hand, it was criticized for being 
responsible for a high incidence of arrhythmias 
and conduction disturbances after resection of LA 
myxomas [28]. In our experience, bi-atrial 
approach (LA incision + RA incision) was used only 
in three cases (17.6%) with huge left atrial 
myxoma attached to the septum not amenable 
for safe resection using an isolated left atrial 
approach. Jones and colleagues in their published 
series reported the use of bi-atrial approach in 
38% of their left atrial myxoma cases [24]. 
The Right atrial trans-septal approach 
facilitates wide excision of the tumor without 
mandating direct handling [27], permits adequate 
mitral exposure, allows inspection of heart 
chambers for concomitant tumors [28], and it 
allows easy repair of a single incision on the right 
atrium; additionally, it was associated with a low 
recurrence rate [1]. In our series, the right atrial 
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trans-septal approach was used successfully in 13 
out of 17 cases (76.4%) of left atrial myxoma. On 
the other hand, Jones and colleagues reported the 
use of a trans-septal approach in 28% of their left 
atrial myxoma cases [24]. The risk of recurrence 
of cardiac myxoma after initial surgical excision is 
unusual with 1-3% incidence during the follow-up 
period [26].  
Most of the reported recurrences were in the 
first four years postoperatively. Patients with 
positive family history, young males and multi-
centric cases are more susceptible to recurrence 
[29]. The possible surgical etiologies of recurrence 
are incomplete resection, excessive intra-
operative manipulations, fragmentation with local 
seeding and embolization [17]. In our series, no 
familial cases and no recurrence were reported.  
Our results revealed that the median 
cardiopulmonary bypass time was 53 min, and the 
median aortic cross-clamp time was 36 minutes. 
There is wide variability in the literature in the 
reported cardiopulmonary bypass and ischemic 
times [7, 30]. This could be attributed to the 
variability in the concomitant procedures; in 
addition to the technique of myxoma resection is 
different from series to series, and it could be 
surgeon related [9, 30]. 
The prognosis for patients with solitary 
myxoma after surgical resection is excellent [7]. 
Concerning our postoperative status, it was found 
that 20 patients were alive (95.3%) and one 
patient had hospital mortality (4.7%). In other 
series, the early postoperative mortality rate was 
2.0%, and the late mortality rate was 6.1% [31]. 
Study limitations: 
Our study has several limitations. First, this is a 
retrospective study; however, this study design is 
appropriate to study rare diseases. Second, the 
number of cases is limited, and this is attributed to 
the rarity of the disease. Third, the comparison 
between the outcomes of the different surgical 
approaches was subjected to bias because most of 
the cases were subjected to right atrial trans-
septal approach, on the other hand, the 
preference of this incision together with its 
excellent outcome should be considered as a 
significant observation. Last, we did not use 
computerized tomography (CT) study for 
preoperative evaluation, and further 
recommendations about its value can’t be drawn. 
Conclusion 
Cardiac myxomas require surgical intervention 
as soon as possible after diagnosis to avoid 
embolic and obstructive complications. During 
surgery, if the principles of extensive resection and 
minimal manipulation of the tumor are respected, 
early and long-term results are excellent. Right 
atrial trans-septal approach fulfills the 
requirements of an ideal incision for excision of 
the left atrial myxoma with the best outcome. 
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